Physiomics (PYC)

 

Latest News

Physiomics extends Virtual Tumour Project

Physiomics has signed further extensions to a Virtual Tumour project with a major global pharmaceutical company, first...

Extensions for Virtual Tumour Project

RNS Number: 2596Y Physiomics PLC 16 May 2016 Physiomics plc ("Physiomics") or ("the Company") Update: 6 th and 7 th extension projects to advance oncology candidate with global pharma company Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed further extensions to a Virtual Tumour proje...

Appointment of part-time Head of Finance

RNS Number: 9357W Physiomics PLC 03 May 2016 Physiomics plc ("Physiomics") or ("the Company") Appointment of Anthony Clayden as part-time Head of Finance The Company announces that Anthony Clayden, of Strategic Finance Director Limited, has been appointed Head of Finance to lead the financial management and provide company secretarial servic...

Physiomics appoints new CEO

Physiomics has confirmed that Dr James Simon Millen is to be appointed Chief Executive Officer of the Company with e...

All News

DateHeadlineSource
16-05-16Physiomics extends Virtual Tumour Project StockMarketWire
16-05-16Extensions for Virtual Tumour ProjectRNS
03-05-16Appointment of part-time Head of FinanceRNS
18-04-16Physiomics appoints new CEOStockMarketWire
18-04-16Physiomics Appoints New Chief Executive OfficerRNS
06-04-16Physiomics to present at AACRStockMarketWire
06-04-16Virtual Tumour Developments Presentation at AACRRNS
04-04-16Physiomics extends contract with pharma companyStockMarketWire
04-04-16New Speciality Pharma Customer for new IndicationRNS
31-03-16FTSE falls on financals after UK current accountStockMarketWire
31-03-16Physiomics' lossStockMarketWire
31-03-16FTSE shies from highs as profiteers hit resourcesStockMarketWire
31-03-16Interim Results StatementRNS
31-03-16Heads of Terms with BioMoti and Board ChangesRNS
22-12-15Issue of OptionsRNS
22-12-15PYC in new contract with speciality pharma customerStockMarketWire
22-12-15New Speciality Pharma Customer for New IndicationRNS
18-12-15PlacingRNS
14-12-15Result of General MeetingRNS
04-12-15Physiomics passes AGM resolutionsStockMarketWire
04-12-15Result of AGMRNS
27-11-15Notice of General MeetingRNS
10-11-15Final ResultsRNS
06-11-15Physiomics identifies potential acquisition targetStockMarketWire
06-11-15Strategic UpdateRNS
12-10-15PYC says 4th large pharma customer for Virtual Tumour StockMarketWire
12-10-154th Large Pharma Customer for Virtual TumourRNS
09-10-15Physiomics inks extension for Virtual Tumour projectStockMarketWire
09-10-15Project extension with global pharma companyRNS
04-08-15Prof. Mark Middleton appointed to Physiomics SABRNS
29-04-15Holding(s) in CompanyRNS
22-04-15Virtual Tumour platform - AACR Annual Meeting 2015RNS
22-04-15Virtual Tumour platform - AACR Annual Meeting 2015RNS
26-03-15Issue of OptionsRNS
17-03-15Half Yearly ReportRNS
12-03-15Issue of EquityRNS
06-03-15Holding(s) in CompanyRNS
04-03-15Holding(s) in CompanyRNS
03-03-15FTSE ends lower as blue-chip trinity weighsStockMarketWire
03-03-15Physiomics' dealStockMarketWire

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory